Deals
Pfizer, Allergan Said to Discuss Making Saunders CEO in Deal
- Eventual split would give Saunders faster-growing business
- Companies said to aim for agreement before Thanksgiving
Allergan CEO: We're Not in the Hostile Deal Business
This article is for subscribers only.
Pfizer Inc. and Allergan Plc are moving toward a plan to make Brent Saunders chief executive officer if the two drug giants reach a takeover agreement, according to people familiar with the matter.
A combined Pfizer and Allergan would probably split into two companies eventually, with Allergan CEO Saunders taking the helm of the faster-growing business of new brand-name drugs, said the people, who asked not to be identified because negotiations are private. The other unit would contain older products at or near the end of their patent lives.